IV iron dextran

DRUG2 trials

Sponsors

Amgen, Beni-Suef University

Conditions

AnemiaESRD (End Stage Renal Disease)Iron Deficiency Anemia (IDA)Non-Myeloid Malignancies

Phase 2

Darbepoetin Alfa With or Without Intravenous (IV) Iron

CompletedNCT00401544

AmgenAnemia, Non-Myeloid Malignancies

Start: 2006-12-31End: 2008-03-31Updated: 2014-01-29

Management of Iron Deficiency Anemia in Hemodialysis Patients

Active, not recruitingNCT07706582

Beni-Suef UniversityESRD (End Stage Renal Disease), Iron Deficiency Anemia (IDA)

Start: 2025-11-02End: 2027-01-01Updated: 2026-07-20